Stargardt Disease Treatment Significantly Improves Vision

Stargardt Disease

94.1% of sufferers with Stargardt Retinal Disease confirmed profit following MD Stem Cell Treatment

USA, October 30, 2022 /EINPresswire.com/ — Stargardt Disease (STGD) is likely one of the extra widespread inherited retinal illnesses, sometimes inflicting lack of imaginative and prescient, clean spots and issues with colour imaginative and prescient. Also known as Stargardt Macular Dystrophy, it’s sometimes from a mutation within the ABC4 gene. Stargardt usually presents in childhood or adolescence and causes lack of imaginative and prescient over time- resulting in authorized blindness. The pure course of the illness is to worsen till imaginative and prescient may be very poor.

WHAT’S NEW:

MD Stem Cells has developed a mobile drugs method to deal with Stargardt and different retinal and optic nerve illnesses. 94.1% of sufferers with Stargardt handled with their method had profit. Their printed paper: Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells within the Treatment of Stargardt Disease has virtually 4000 views of the summary and key factors.

ACTUAL RESULTS:

Of Stargardt sufferers handled, 94.1% confirmed improved or steady imaginative and prescient within the observe up interval; 76.5% had visible acuity enchancment in a single or each eyes and 17.6% stabilized their imaginative and prescient within the observe up interval . Both eyes had been handled within the examine: a complete of 85.3% of handled eyes confirmed profit with 61.8% exhibiting visible enchancment and 23.5% remaining steady within the observe up interval. The outcomes had been extremely statistically significant- the gold customary in drugs that reveals the process was accountable for the advantages. There had been no opposed occasions or issues with the remedy.

WHAT IS THE TREATMENT:

The Stem Cell Ophthalmology Treatment Study II ( SCOTS2) makes use of the affected person’s personal stem cells for remedy. The affected person is sedated and there’s no ache. They harvest a small portion of the affected person’s bone marrow, separate the lively stem cell inhabitants, and deal with the affected person with 2 ocular injections adopted by intravenous- all beneath a brief interval of anesthesia.

OTHER EYE DISEASES THIS CAN HELP:

MD Stem Cells has handled quite a lot of eye illnesses and proven enchancment. In addition to Stargardt, these embody AMD (macular degeneration), Retinitis Pigmentosa, Usher, Cone-Rod, Rod-Cone, Cone dystrophy, Bests dystrophy, non-perfusion retinopathy, retinal harm, retinal irritation equivalent to POHS or choroiditis, sure diabetic retinopathies and sure put up Retinal Detachment imaginative and prescient loss. Numerous optic nerve circumstances have additionally responded together with Glaucoma, NAION, LHON, ADOA, optic nerve ischemia/ neuropathy/ optic neuritis/optic atrophy/ and optic nerve compression.

KEY POINTS:

MD Stem Cells has huge expertise with eye illness and has printed a number of medical and scientific papers. This is reassuring to sufferers and well being care suppliers looking for remedy choices. MD Stem Cells has the data to rigorously deal with your retinal or optic nerve situation, if acceptable, resulting in optimum outcomes.

I WANT MORE INFORMATION:

Receive details about collaborating in SCOTS2 by emailing Dr. Levy at [email protected] along with your title, cellphone, electronic mail tackle and transient historical past of their illness. You may use the contact us web page on www.mdstemcells.com or name immediately 203-423-9494. MD Stem Cells has no grant help and isn’t a pharmaceutical firm; it is a affected person sponsored research and the sufferers pay for each remedy and journey.

Steven Levy
MD Stem Cells
+1 203-423-9494
[email protected]
Visit us on social media:
Facebook